ICD9Data.com   Free 2008 ICD-9-CM Database

2008 ICD-9-CM Volume 1 Diagnosis Codes Home > Neoplasms 140-239 > Malignant Neoplasm Of Lymphatic And Hematopoietic Tissue 200-208 > ICD-9-CM Diagnosis 202 Other malignant neoplasms of lymphoid and histiocytic tissue 202 is a non-specific code that cannot be used to specify a diagnosis ICD-9-CM Diagnosis 202.0 Nodular lymphoma A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin's lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001). -- 2003 Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the lymph nodes. The nodules resemble to some extent the germinal centers of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-lymphocytes. This class of lymphoma usually occurs in older persons, is commonly multinodal, and possibly extranodal. Patients whose lymphomas present a follicular or nodular pattern generally have a more indolent course than those presenting with a diffuse pattern. see also M-9675/3 202.0 is a non-specific code that cannot be used to specify a diagnosis 202.0 contains 54 index entries ICD-9-CM Diagnosis 202.00 Nodular lymphoma unspecified site 202.00 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.01 Nodular lymphoma involving lymph nodes of head face and neck 202.01 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.02 Nodular lymphoma involving intrathoracic lymph nodes 202.02 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.03 Nodular lymphoma involving intra-abdominal lymph nodes 202.03 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.04 Nodular lymphoma involving lymph nodes of axilla and upper limb 202.04 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.05 Nodular lymphoma involving lymph nodes of inguinal region and lower limb 202.05 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.06 Nodular lymphoma involving intrapelvic lymph nodes 202.06 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.07 Nodular lymphoma involving spleen 202.07 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.08 Nodular lymphoma involving lymph nodes of multiple sites 202.08 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.1 Mycosis fungoides (mye-KO-sis fun-GOY-deez) A type of non-Hodgkin's lymphoma that first appears on the skin and can spread to the lymph nodes or other organs such as the spleen, liver, or lungs. A chronic malignant T-cell lymphoma of the skin. In the late stages the lymph nodes and viscera are affected. A peripheral (mature) T-cell lymphoma presenting in the skin with patches/plaques and it is characterized by epidermal and dermal infiltration of small to medium-sized T-cells with cerebriform nuclei. Patients with limited disease generally have an excellent prognosis. In the more advanced stages, the prognosis is poor. (WHO, 2001) -- 2003 202.1 is a non-specific code that cannot be used to specify a diagnosis 202.1 contains 8 index entries ICD-9-CM Diagnosis 202.10 Mycosis fungoides unspecified site 202.10 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.11 Mycosis fungoides involving lymph nodes of head face and neck 202.11 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.12 Mycosis fungoides involving intrathoracic lymph nodes 202.12 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.13 Mycosis fungoides involving intra-abdominal lymph nodes 202.13 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.14 Mycosis fungoides involving lymph nodes of axilla and upper limb 202.14 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.15 Mycosis fungoides involving lymph nodes of inguinal region and lower limb 202.15 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.16 Mycosis fungoides involving intrapelvic lymph nodes 202.16 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.17 Mycosis fungoides involving spleen 202.17 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.18 Mycosis fungoides involving lymph nodes of multiple sites 202.18 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.2 Sezary's disease A form of cutaneous T-cell lymphoma manifested by generalized exfoliative erythroderma, intense pruritus, peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear cells in the skin, lymph nodes, and peripheral blood (Sezary cells). (Dorland, 27th ed) A form of cutaneous T-cell lymphoma, a cancerous disease that affects the skin. A generalized peripheral (mature) T-cell neoplasm characterized by the presence of erythroderma, lymphadenopathy, and neoplastic, cerebriform T-lymphocytes in the blood. Sezary syndrome is an aggressive disease. (WHO, 2001) -- 2003 202.2 is a non-specific code that cannot be used to specify a diagnosis 202.2 contains 4 index entries ICD-9-CM Diagnosis 202.20 Sezary's disease unspecified site 202.20 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.21 Sezary's disease involving lymph nodes of head face and neck 202.21 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.22 Sezary's disease involving intrathoracic lymph nodes 202.22 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.23 Sezary's disease involving intra-abdominal lymph nodes 202.23 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.24 Sezary's disease involving lymph nodes of axilla and upper limb 202.24 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.25 Sezary's disease involving lymph nodes of inguinal region and lower limb 202.25 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.26 Sezary's disease involving intrapelvic lymph nodes 202.26 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.27 Sezary's disease involving spleen 202.27 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.28 Sezary's disease involving lymph nodes of multiple sites 202.28 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.3 Malignant histiocytosis A rare, usually rapidly progressive disorder, characterized by abrupt onset, fever, weight loss, hepato-splenomegaly, pancytopenia, and lymphadenopathy. An aggressive Non-Hodgkin's adult lymphoma, comprised of two clinical syndromes: nasal T-cell lymphoma (previously called lethal midline granuloma) and pulmonary angiocentric B-cell lymphoma (previously called lymphomatoid granulomatosis). (PDQ) 202.3 is a non-specific code that cannot be used to specify a diagnosis 202.3 contains 5 index entries ICD-9-CM Diagnosis 202.30 Malignant histiocytosis unspecified site 202.30 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.31 Malignant histiocytosis involving lymph nodes of head face and neck 202.31 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.32 Malignant histiocytosis involving intrathoracic lymph nodes 202.32 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.33 Malignant histiocytosis involving intra-abdominal lymph nodes 202.33 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.34 Malignant histiocytosis involving lymph nodes of axilla and upper limb 202.34 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.35 Malignant histiocytosis involving lymph nodes of inguinal region and lower limb 202.35 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.36 Malignant histiocytosis involving intrapelvic lymph nodes 202.36 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.37 Malignant histiocytosis involving spleen 202.37 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.38 Malignant histiocytosis involving lymph nodes of multiple sites 202.38 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.4 Leukemic reticuloendotheliosis A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow. A rare neoplasm of small B-lymphocytes with "hairy" projections in bone marrow, spleen and peripheral blood. Most patients are middle-aged to elderly adults and present with splenomegaly and pancytopenia. (WHO, 2001) -- 2003 A type of chronic leukemia in which the abnormal white blood cells appear to be covered with tiny hairs when viewed under a microscope. 202.4 is a non-specific code that cannot be used to specify a diagnosis 202.4 contains 2 index entries ICD-9-CM Diagnosis 202.40 Leukemic reticuloendotheliosis unspecified site 202.40 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.41 Leukemic reticuloendotheliosis involving lymph nodes of head face and neck 202.41 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.42 Leukemic reticuloendotheliosis involving intrathoracic lymph nodes 202.42 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.43 Leukemic reticuloendotheliosis involving intra-abdominal lymph nodes 202.43 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.44 Leukemic reticuloendotheliosis involving lymph nodes of axilla and upper arm 202.44 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.45 Leukemic reticuloendotheliosis involving lymph nodes of inguinal region and lower limb 202.45 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.46 Leukemic reticuloendotheliosis involving intrapelvic lymph nodes 202.46 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.47 Leukemic reticuloendotheliosis involving spleen 202.47 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.48 Leukemic reticuloendotheliosis involving lymph nodes of multiple sites 202.48 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.5 Letterer-siwe disease Acute, disseminated, rapidly progressive form of Langerhans-cell histiocytosis. 202.5 is a non-specific code that cannot be used to specify a diagnosis 202.5 contains 9 index entries ICD-9-CM Diagnosis 202.50 Letterer-siwe disease unspecified site 202.50 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.51 Letterer-siwe disease involving lymph nodes of head face and neck 202.51 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.52 Letterer-siwe disease involving intrathoracic lymph nodes 202.52 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.53 Letterer-siwe disease involving intra-abdominal lymph nodes 202.53 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.54 Letterer-siwe disease involving lymph nodes of axilla and upper limb 202.54 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.55 Letterer-siwe disease involving lymph nodes of inguinal region and lower limb 202.55 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.56 Letterer-siwe disease involving intrapelvic lymph nodes 202.56 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.57 Letterer-siwe disease involving spleen 202.57 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.58 Letterer-siwe disease involving lymph nodes of multiple sites 202.58 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.6 Malignant mast cell tumors A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis. A rare entity characterized by localized but destructive growth of a tumor consisting of highly atypical, immature mast cells.(WHO, 2001) -- 2003 A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow. A variant of mastocytosis characterized by multifocal, dense infiltrates of mast cells (15 or more mast cells in aggregates) detected in the bone marrow and/or other extracutaneous sites. (WHO, 2001) -- 2003 202.6 is a non-specific code that cannot be used to specify a diagnosis 202.6 contains 10 index entries ICD-9-CM Diagnosis 202.60 Malignant mast cell tumors unspecified site 202.60 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.61 Malignant mast cell tumors involving lymph nodes of head face and neck 202.61 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.62 Malignant mast cell tumors involving intrathoracic lymph nodes 202.62 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.63 Malignant mast cell tumors involving intra-abdominal lymph nodes 202.63 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.64 Malignant mast cell tumors involving lymph nodes of axilla and upper limb 202.64 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.65 Malignant mast cell tumors involving lymph nodes of inguinal region and lower limb 202.65 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.66 Malignant mast cell tumors involving intrapelvic lymph nodes 202.66 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.67 Malignant mast cell tumors involving spleen 202.67 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.68 Malignant mast cell tumors involving lymph nodes of multiple sites 202.68 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.7 Peripheral t-cell lymphoma 202.7 is a specific code that can be used to specify a diagnosis 202.7 contains 2 index entries ICD-9-CM Diagnosis 202.8 Other malignant lymphomas (lim-FO-ma) Cancer that arises in cells of the lymphatic system. A general term for various neoplastic diseases of the lymphoid tissue. A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003 An obsolete term for a malignant tumor of lymphatic tissue. Malignant lymphoma in which neoplastic cells diffusely infiltrate the entire lymph node without any definite organized pattern. Patients whose lymphomas present a diffuse pattern generally have a more unfavorable survival outlook than those presenting with a follicular or nodular pattern. 202.8 is a non-specific code that cannot be used to specify a diagnosis 202.8 contains 17 index entries ICD-9-CM Diagnosis 202.80 Other malignant lymphomas unspecified site 202.80 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.81 Other malignant lymphomas involving lymph nodes of head face and neck 202.81 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.82 Other malignant lymphomas involving intrathoracic lymph nodes 202.82 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.83 Other malignant lymphomas involving intra-abdominal lymph nodes 202.83 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.84 Other malignant lymphomas involving lymph nodes of axilla and upper limb 202.84 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.85 Other malignant lymphomas involving lymph nodes of inguinal region and lower limb 202.85 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.86 Other malignant lymphomas involving intrapelvic lymph nodes 202.86 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.87 Other malignant lymphomas involving spleen 202.87 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.88 Other malignant lymphomas involving lymph nodes of multiple sites 202.88 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.9 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue A neoplastic proliferation of Langerhans cells with overtly malignant cytologic features. It can be considered a higher grade variant of Langerhans cell histiocytosis (LCH) and it can present de novo or progress from antecedent LCH. (WHO, 2001) -- 2003 Malignant neoplasms that either originate from the bone marrow (e.g. myeloid leukemias) or involve the bone marrow as secondary-metastatic tumors (e.g. metastatic carcinomas to the bone marrow). --2003 202.9 is a non-specific code that cannot be used to specify a diagnosis 202.9 contains 5 index entries ICD-9-CM Diagnosis 202.90 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue unspecified site 202.90 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.91 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving lymph nodes of head face and neck 202.91 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.92 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving intrathoracic lymph nodes 202.92 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.93 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving intra-abdominal lymph nodes 202.93 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.94 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving lymph nodes of axilla and upper limb 202.94 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.95 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving lymph nodes of inguinal region and lower limb 202.95 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.96 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving intrapelvic lymph nodes 202.96 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.97 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving spleen 202.97 is a specific code that can be used to specify a diagnosis ICD-9-CM Diagnosis 202.98 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving lymph nodes of multiple sites 202.98 is a specific code that can be used to specify a diagnosis